Annual Working Capital
$334.30 M
+$122.41 M+57.77%
31 December 2023
Summary:
Protagonist Therapeutics annual working capital is currently $334.30 million, with the most recent change of +$122.41 million (+57.77%) on 31 December 2023. During the last 3 years, it has risen by +$37.58 million (+12.67%). PTGX annual working capital is now at all-time high.PTGX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$432.19 M
-$97.16 M-18.35%
30 September 2024
Summary:
Protagonist Therapeutics quarterly working capital is currently $432.19 million, with the most recent change of -$97.16 million (-18.35%) on 30 September 2024. Over the past year, it has increased by +$97.89 million (+29.28%). PTGX quarterly working capital is now -26.45% below its all-time high of $587.64 million, reached on 31 March 2024.PTGX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +29.3% |
| 3 y3 years | +12.7% | +45.7% |
| 5 y5 years | +204.2% | +293.2% |
PTGX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +57.8% | -26.4% | +104.0% |
| 5 y | 5 years | at high | +204.2% | -26.4% | +382.3% |
| alltime | all time | at high | +3804.0% | -26.4% | +3800.6% |
Protagonist Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $432.19 M(-18.4%) |
| June 2024 | - | $529.35 M(-9.9%) |
| Mar 2024 | - | $587.64 M(+75.8%) |
| Dec 2023 | $334.30 M(+57.8%) | $334.30 M(+12.6%) |
| Sept 2023 | - | $297.01 M(+2.2%) |
| June 2023 | - | $290.54 M(+36.7%) |
| Mar 2023 | - | $212.51 M(+0.3%) |
| Dec 2022 | $211.90 M(-28.6%) | $211.90 M(-11.7%) |
| Sept 2022 | - | $239.86 M(-9.2%) |
| June 2022 | - | $264.21 M(-11.4%) |
| Mar 2022 | - | $298.07 M(+0.5%) |
| Dec 2021 | $296.72 M(+7.8%) | $296.72 M(+2.8%) |
| Sept 2021 | - | $288.53 M(-12.3%) |
| June 2021 | - | $328.85 M(+31.0%) |
| Mar 2021 | - | $250.99 M(-8.9%) |
| Dec 2020 | $275.37 M | $275.37 M(+66.3%) |
| Sept 2020 | - | $165.59 M(-9.1%) |
| June 2020 | - | $182.11 M(+103.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $89.61 M(-18.5%) |
| Dec 2019 | $109.91 M(-1.3%) | $109.91 M(-3.0%) |
| Sept 2019 | - | $113.25 M(+8.9%) |
| June 2019 | - | $104.00 M(+5.6%) |
| Mar 2019 | - | $98.50 M(-11.5%) |
| Dec 2018 | $111.34 M(+2.7%) | $111.34 M(-9.8%) |
| Sept 2018 | - | $123.40 M(+15.2%) |
| June 2018 | - | $107.09 M(-1.1%) |
| Mar 2018 | - | $108.31 M(-0.1%) |
| Dec 2017 | $108.39 M(+41.1%) | $108.39 M(+138.4%) |
| Sept 2017 | - | $45.46 M(-23.9%) |
| June 2017 | - | $59.76 M(-0.0%) |
| Mar 2017 | - | $59.77 M(-22.2%) |
| Dec 2016 | $76.81 M(+593.2%) | $76.81 M(-20.7%) |
| Sept 2016 | - | $96.90 M(+429.3%) |
| June 2016 | - | $18.31 M(-30.8%) |
| Mar 2016 | - | $26.47 M(+138.9%) |
| Dec 2015 | $11.08 M(+29.4%) | $11.08 M |
| Dec 2014 | $8.56 M | - |
FAQ
- What is Protagonist Therapeutics annual working capital?
- What is the all time high annual working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly working capital year-on-year change?
What is Protagonist Therapeutics annual working capital?
The current annual working capital of PTGX is $334.30 M
What is the all time high annual working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual working capital is $334.30 M
What is Protagonist Therapeutics quarterly working capital?
The current quarterly working capital of PTGX is $432.19 M
What is the all time high quarterly working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly working capital is $587.64 M
What is Protagonist Therapeutics quarterly working capital year-on-year change?
Over the past year, PTGX quarterly working capital has changed by +$97.89 M (+29.28%)